SCHEMBL6168232

SCHEMBL6168232

CC(=O)/C(=C/c1cccc(Cl)c1)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 3/20 0.59
KMT2A Q03164 6/20 0.56
KDM4E B2RXH2 4/20 0.56
ALDH1A1 P00352 4/20 0.56
POLB P06746 2/20 0.56
PKM P14618 1/20 0.56
MAOB P27338 1/20 0.55
LMNA P02545 5/20 0.52
MAPT P10636 5/20 0.52
NPSR1 Q6W5P4 3/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
NPC1 O15118 2/20 0.52
NTSR1 P30989 1/20 0.52
MEN1 O00255 5/20 0.51
AKR1C1 Q04828 3/20 0.50
AKR1C2 P52895 2/20 0.50
GAA P10253 1/20 0.49
CYP2C9 P11712 2/20 0.46
CYP1A2 P05177 1/20 0.46
FBP1 P09467 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6168237 1.00 AKR1C3 (0.59) AKR1C3KMT2AKDM4EALDH1A1POLB
SCHEMBL5183481 0.83 AKR1C1 (0.70) AKR1C3KMT2AKDM4EALDH1A1POLB
SCHEMBL7992874 0.83 AKR1C1 (0.70) AKR1C3KMT2AKDM4EALDH1A1POLB
SCHEMBL6172379 0.83 AKR1C1 (0.70) AKR1C3KMT2AKDM4EALDH1A1POLB
SCHEMBL6169410 0.82 ALDH1A1 (0.55) AKR1C3KMT2AKDM4EALDH1A1POLB
SCHEMBL6169411 0.82 ALDH1A1 (0.55) AKR1C3KMT2AKDM4EALDH1A1POLB
SCHEMBL11079773 0.82 HTT (0.55) AKR1C3KMT2AKDM4EALDH1A1POLB
SCHEMBL11079768 0.82 HTT (0.55) AKR1C3KMT2AKDM4EALDH1A1POLB
SCHEMBL6176859 0.82 AKR1C3 (0.50) AKR1C3KMT2AKDM4EALDH1A1POLB
SCHEMBL6176863 0.82 AKR1C3 (0.50) AKR1C3KMT2AKDM4EALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1528059-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle LLC (US) 2005-05-04 EP disclosed
EP-0809636-B1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-09-04 EP disclosed
EP-1223167-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle & Co. (US) 2002-07-17 EP disclosed
US-5859257-A ANTIINFLAMMATORY, ANTIARTHRITIC AGENTS G. D. SEARLE & CO. (US) 1999-01-12 US disclosed
US-4791122-A HYPOTENSIVE AGENTS, ANTIARRHYTHMIA AGENTS BAYER AKTIENGESELLSCHAFT (DE) 1988-12-13 US disclosed